SUMMARYIn this brief communication we describe the occurrence of a KPC-producing Serratia marcescensisolate in a home-care patient from Recife, Brazil. The bla
KPC, bla
SPM, bla
IMP, bla
VIM
bla
OXA, bla
CTX-M, bla
SHV, bla
TEM and bla
GES genes were investigated by Polymerase Chain Reaction (PCR) and DNA sequencing. The isolate was positive for bla
KPC-2 and bla
TEM-1 and was resistant to aztreonam, cefepime, cefotaxime, imipenem, meropenem, gentamicin, ciprofloxacin and cefazidime, and susceptible only to amikacin, tigecycline and gatifloxacin. This is the first report in Brazil of KPC-producing S. marcescens clinical isolate outside of a hospital environment. Caregivers should be alert for the presence of this isolate in the community setting.